RHOC and hepatocellular carcinoma: There were a number of limitations present in this study, including the use of Huh7 cells derived from a hepatoma, the lack of a secondary proteomic assay for GNB1, and the use of RHOA/RHOC antibody instead of a RHOC-specific antibody.